China Medicine Stock Market Value
CHME Stock | USD 0.0002 0.00 0.00% |
Symbol | China |
China Medicine 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to China Medicine's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of China Medicine.
11/02/2024 |
| 12/02/2024 |
If you would invest 0.00 in China Medicine on November 2, 2024 and sell it all today you would earn a total of 0.00 from holding China Medicine or generate 0.0% return on investment in China Medicine over 30 days. China Medicine is related to or competes with Cardinal Health, Henry Schein, Owens Minor, and Patterson Companies. China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicin... More
China Medicine Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure China Medicine's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess China Medicine upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | 0.1119 | |||
Maximum Drawdown | 100.0 |
China Medicine Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for China Medicine's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as China Medicine's standard deviation. In reality, there are many statistical measures that can use China Medicine historical prices to predict the future China Medicine's volatility.Risk Adjusted Performance | 0.1035 | |||
Jensen Alpha | 1.87 | |||
Total Risk Alpha | (0.55) | |||
Treynor Ratio | (0.52) |
China Medicine Backtested Returns
China Medicine is out of control given 3 months investment horizon. China Medicine secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12% return per unit of risk over the last 3 months. We have collected data for sixteen different technical indicators, which can help you to evaluate if expected returns of 1.54% are justified by taking the suggested risk. Use China Medicine Mean Deviation of 2.98, standard deviation of 12.31, and Risk Adjusted Performance of 0.1035 to evaluate company specific risk that cannot be diversified away. China Medicine holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -2.88, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning China Medicine are expected to decrease by larger amounts. On the other hand, during market turmoil, China Medicine is expected to outperform it. Use China Medicine information ratio, as well as the relationship between the skewness and day median price , to analyze future returns on China Medicine.
Auto-correlation | 0.00 |
No correlation between past and present
China Medicine has no correlation between past and present. Overlapping area represents the amount of predictability between China Medicine time series from 2nd of November 2024 to 17th of November 2024 and 17th of November 2024 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of China Medicine price movement. The serial correlation of 0.0 indicates that just 0.0% of current China Medicine price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.0 | |
Spearman Rank Test | 1.0 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
China Medicine lagged returns against current returns
Autocorrelation, which is China Medicine pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting China Medicine's pink sheet expected returns. We can calculate the autocorrelation of China Medicine returns to help us make a trade decision. For example, suppose you find that China Medicine has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
China Medicine regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If China Medicine pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if China Medicine pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in China Medicine pink sheet over time.
Current vs Lagged Prices |
Timeline |
China Medicine Lagged Returns
When evaluating China Medicine's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of China Medicine pink sheet have on its future price. China Medicine autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, China Medicine autocorrelation shows the relationship between China Medicine pink sheet current value and its past values and can show if there is a momentum factor associated with investing in China Medicine.
Regressed Prices |
Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in China Pink Sheet
China Medicine financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Medicine security.